Call for CASES Motaz AbuSamra Krzysztof Milewski CCU, Upper-Silesian Center of Cardiology, Silesian Medical School, Katowice, Poland Head of Department:

Slides:



Advertisements
Similar presentations
MAIN-COMPARE Study – Disclosure Information
Advertisements

Marek Kondys, MD Paweł Buszman, MD, FESC, FACC
Multivessel PCI procedure complicated with fracture of the wire Marcin D ę binski, MD Head: Pawel E. Buszman, MD, FACC University Hospital of Silesia,
Is this the “spioenkop” for CABG?
Introduction Recent guidelines considered PCI to be a potential alternative to CABG for ULMCA stenosis, based on several large registries and randomized.
ISCHAEMIC HEART DISEASE Acute Coronary Syndromes JD Marx Department of Cardiology University of the Free State.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
A PROSPECTIVE MULTICENTRE REGISTRY FOR THE ASSESSMENT OF SAFETY AND EFFICACY OF BIODEGRADABLE POLYMER COATED, PACLITAXEL ELUTING STENT LUC TM * *(BALTON,
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
HEAPHY 1 & 2 CASE RACE 1 – DIAG Rowena OLIVER Sat 31 st Aug 2013 Session 3 / CR1-6 13:26 – 13:30 OTAGO / SOUTHLAND ABSTRACT A case of a 81 year old female.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Call for CASES One Stage Coronary And Peripheral Intervention (OCAPI) in a patient with accelerated diffuse atherosclerosis after chest irradiation. One.
Call for CASES Staged PCI in a patient with multivessel coronary disease disqualified from CABG. Pawel Buszman, MD, FESC, FSCAI Marcin Debinski, MD Krzysztof.
Call for CASES Leszek D. Stachaczyk, MD Pawel Buszman, MD, FESC, FSCAI American Heart of Poland, Ustroñ, Poland & CCU, Upper-Silesian Center of Cardiology,
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
‘Taxi Driver in Pain’ Tiara Gill Carrie Ross Mark Hambly.
Percutaneous closure of a coronary fistula Pawel Buszman, MD Silesian Medical School Katowice, Poland.
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:
Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland.
Multi-vessel disease and intracoronay physiology Combat MI 2009 Kees-joost Botman MD, PhD Catharina hospital Eindhoven Heart Institute The Netherlands.
VULNERABLE PLAQUES: Pertinent doubts and solutions in interventional cardiology EuroPCR Paris, 16 May 2006.
Call for CASES Silesian Medical School, Katowice, Poland Percutenous Controlled Reperfusion For STEMI P iotr P. Buszman.
IVUS evaluation TAP technology for unprotected left main bifurcation lesions interventional therapy Yong-Sheng Ke. MD Department of Cardiology, Yijishan.
One patient, two years, three choices, four PCI ZHAO Peng Cardiology , the Affiliated Hospital of Medical College of CPAPF, Tianjin, China.
Occluded Artery Trial (OAT) Presented at The American Heart Association Scientific Session 2006 Presented by Dr. Judith S. Hochman OAT Trial.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
Range & Specifications CASE #1: 80% stenosis of the left renal artery located at the ostium of the vessel. HELIOS 6x13.
2009 CIT CASE REVIEW Li Weijie Department of Cardiovascular Medicine, Xijing Hospital.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for.
Multivessel Coronary Artery Disease
Ted Feldman MD, FACC, FESC, FSCAI Disclosure Information The following relationships exist: Grant support: Abbott, BSC, Edwards, St Jude, WL Gore Consultant:
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
J Am Coll Cardiol 2008;51:538–45 Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical Revascularization Pawel E. Buszman,
Ms. Leonardo Roever Coronary Stents. Coronary Artery Disease Leading cause of death in United States for men and women Caused by buildup of plaque in.
Total Occlusion Study of Canada (TOSCA-2) Trial
ISCHEMIC HEART DISEASE
Adel Gamal, MD and Mohamed Saber, Msc
Cardiology Division, Jeju National University Hospital, Jeju, KOREA
Successful transdradial removal of a dislodged coronary stent
Nightmares in the Cath Lab
New Generation Resolute Integrity Drug-Eluting Stent Superior to Benchmark Xience Drug-Eluting Stent: Primary Endpoint Results from the PROPEL Study –
Specialist Cardiologist at Sydney. Macquarie University Hospital Cardiology at Macquarie University Hospital, a team of specialist cardiologist, who diagnose.
Special Hospital for surgical diseases “Filip Vtori”, Skopje
Damian Gimpel Waikato Cardiothoracic Unit Journal Club
Clinical Presentation
Tarek Abou Ghazala, MD, FACC, FSCAI
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
Acute and Mid-Term Outcomes of Coronary Stent Implantation for the Treatment of Unprotected Left Main Coronary Artery Disease Dr mahmoud ebrahimi Dr hosein.
Meruzhan Saghatelyan, MD, Interventional cardiologist
Intra-Aortic Balloon Pump For Complex Calcified Left-Main Bifurcation Lesion Supawat Ratanapo, MD Medical College of Georgia, Augusta University.
Complex PCI to CTO lesion in RCA with nightmares complications
PCI in patients with cardiogenic shock associated with acute occlusion of the left main coronary artery.
Fractional Flow Reserve Workshop
Case presentantion 73-year old female
R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R
Unstable Angina and Non–ST Elevation Myocardial Infarction
Chapter 28 Management of Patients With Coronary Vascular Disorders
Giuseppe Biondi Zoccai, MD
The European Society of Cardiology Presented by RJ De Winter
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Impact of Diabetes Mellitus on Long-term Outcomes in the
Maintenance of Long-Term Clinical Benefit with
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
Atlantic Cardiovascular Patient Outcomes Research Team
R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R
Presentation transcript:

Call for CASES Motaz AbuSamra Krzysztof Milewski CCU, Upper-Silesian Center of Cardiology, Silesian Medical School, Katowice, Poland Head of Department: Pawel Buszman, MD, FESC, FSCAI Motaz AbuSamra Krzysztof Milewski CCU, Upper-Silesian Center of Cardiology, Silesian Medical School, Katowice, Poland Head of Department: Pawel Buszman, MD, FESC, FSCAI Stent recoil after LM stenting

Description of the problem 56-years old man with unstable angina pectoris reffered to ICCU at Upper Silesian Heart Center beacuse of LM disease and CTO of RCA. Medical History: Inferior Myocardial Infarction (2000). Risk factors: hipertonia arterialis. Concomitant treatment: ASA, isosorbide mononitrate, B- blocker, ACE, statin ECG: Q wave in II, III, aVF and T wave inversion in III, aVF. LVEF assessed by echocardiography: 60%. Enzymes: Troponin: negative CPK-MB: 9 U/L Euroscoure : 2

Baseline coronarography Coronary angiography showed severe LM stenosis and RCA occlusion (Syntax score = 3 ) Consultants’ Team (Interventional cardiologist and Cardiac Surgeons) decided to send the patient for ULMCA stenting.

PCI procedure Administration of ticlopidine and ASA. Routine anticoagulation during procedure. Guiding catheter: Judkins Left 4.0 7F. Taxus stent (4.5x12mm) implantation to the LM ostium under the pessure of 18 atm (direct stenting). Residual stenosis c.a. 50%- stent recoil phenomenon.

PCI procedure Renal stent (NEFRO, Balton) implantation into the previously implanted Taxus stent Size: 5,0x8mm Inflation pressure: 16 atm

Residual stenosis: 0%. TIMI flow: 3 No complication. No ECG changes in comparison with baseline. Two days after the procedure patient was discharged in good health with no complication. After PCI

Seven months f-up Seven months later the patient was controlled with coronary angiography There was no restenosis in LM. CCS class: I

Similarity of ostial LM and renal artery disease I.Similarities in vessel wall structures II.Fibrotic/calcified lesions III.Large vessels (>5mm) IV.Elastic recoil V.40-50% coincident rate VI.The same type of disease? VII.PTA/PCI: large stents with high radial forces/support, delivered under high pressure

Summary A 56 year old male with unstable angina was admitted to the hospital for interventional diagnosis and treatment. Coronary angiography showed severe LM stenosis After TAXUS stent implantation the recoil phenomenon was observed. It was succesfuly treatet with renal „NEFRO” stent implantation Patient left hospital on combined antiplatelet therapy with aspirin and ticlopidine ordered for 6 months. After 7 months patient was angiographically controlled and no LM stenosis was observed Application of renal „NEFRO” stent is feasible and efficient for leasions locaeted in LM with high elastic force